Department of Psychiatry, Vermont Center on Behavior & Health, University of Vermont, 1 South Prospect Street, SATC-UHC, Burlington, VT 05401, United States.
Department of Psychiatry, Vermont Center on Behavior & Health, University of Vermont, 1 South Prospect Street, SATC-UHC, Burlington, VT 05401, United States; Department of Psychological Science, Vermont Center on Behavior & Health, University of Vermont, 1 South Prospect Street, SATC-UHC, Burlington, VT 05401, United States.
Addict Behav. 2019 Dec;99:106112. doi: 10.1016/j.addbeh.2019.106112. Epub 2019 Aug 26.
Individuals with drug use disorders or affective disorders have higher cigarette smoking prevalence and smoking intensity and are less likely to quit than the general population. We sought to estimate the prevalence of cigarette smoking by drug use and psychiatric diagnoses and to explore to what extent a co-occurring diagnosis was associated with current smoking.
Data were derived from the most recent National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III, 2012-2013; n = 36,309). Cigarette smoking status was examined among those with any past-year or lifetime drug use disorders (i.e., alcohol, cannabis, opioid, cocaine) or affective disorders (i.e., mood, anxiety). Diagnoses were assessed using the Diagnostic and Statistical Manual of Mental Disorders criteria (DSM-5).
Adjusting for sociodemographic characteristics, those with drug use disorders (past-year AOR = 3.3, 95% CI: 3.0, 3.6; lifetime AOR = 3.2, 95% CI: 3.0, 3.5) and those with affective disorders (past-year AOR = 1.7; 95%CI: 1.5, 1.8, lifetime AOR = 1.3, 95% CI: 1.2; 1.4), had higher odds of current cigarette smoking compared to individuals with no diagnosis. The odds of current cigarette smoking was significantly higher in individuals with both drug use disorders and affective disorders compared to those with either a drug use or affective disorder or no disorder (past-year AOR = 5.1; 95% CI: 4.3, 5.9, lifetime AOR = 4.3; 95% CI: 3.8, 4.7).
Approximately 30% of the population had a past-year drug use or affective disorder, 17% of whom report both. The combination of both diagnoses produced a 1.5 to 3-fold higher correlation with smoking than either alone.
与普通人群相比,患有药物使用障碍或情感障碍的个体吸烟率和吸烟强度更高,戒烟的可能性也更低。我们旨在评估药物使用和精神诊断与吸烟的相关性,并探索共病诊断与当前吸烟之间的关系。
数据来自最新的国家酒精和相关条件流行病学调查-III(NESARC-III,2012-2013 年;n=36309)。在过去一年或终生患有任何药物使用障碍(即酒精、大麻、阿片类药物、可卡因)或情感障碍(即情绪、焦虑)的人群中,检查吸烟状况。使用精神障碍诊断和统计手册第五版(DSM-5)标准评估诊断。
调整社会人口统计学特征后,与没有诊断的人相比,患有药物使用障碍(过去一年的优势比(AOR)=3.3,95%置信区间[CI]:3.0,3.6;终生 AOR=3.2,95%CI:3.0,3.5)和患有情感障碍(过去一年 AOR=1.7;95%CI:1.5,1.8;终生 AOR=1.3,95%CI:1.2;1.4)的个体,当前吸烟的可能性更高。与患有药物使用障碍或情感障碍,或没有任何障碍的个体相比,同时患有药物使用障碍和情感障碍的个体当前吸烟的可能性显著更高(过去一年 AOR=5.1;95%CI:4.3,5.9;终生 AOR=4.3;95%CI:3.8,4.7)。
大约 30%的人群患有过去一年的药物使用障碍或情感障碍,其中 17%的人同时患有这两种障碍。这两种诊断的组合与吸烟的相关性比任何一种单独诊断都高出 1.5 至 3 倍。